Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

NCT05750589 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Corneal Endothelial Cell Density Changes In Healthy Subjects, When Administered ISV-403 for 5 Days

NCT01120418 ·Status: COMPLETED ·Phase: PHASE1

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

NCT03814291 ·Status: COMPLETED ·Phase: PHASE1

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

NCT02599064 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.

NCT07329686 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration

NCT00877032 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

NCT00383370 ·Status: COMPLETED ·Phase: PHASE1

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

NCT04085341 ·Status: COMPLETED ·Phase: PHASE2

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

NCT00473928 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

NCT00138632 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

NCT03699618 ·Status: TERMINATED

Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

NCT06737354 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD

NCT05972473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

NCT01940887 ·Status: TERMINATED ·Phase: PHASE3

A Study of IBI302 in Patients With nAMD

NCT04820452 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD

NCT07275840 ·Status: RECRUITING ·Phase: PHASE2

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

NCT01089517 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Oral CM082 in Patients With wAMD

NCT03710863 ·Status: UNKNOWN ·Phase: PHASE2

Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients

NCT04370379 ·Status: COMPLETED ·Phase: PHASE1

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

NCT00041483 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4

NCT07241169 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

NCT04964089 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

NCT02061865 ·Status: COMPLETED ·Phase: PHASE1

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

NCT02450981 ·Status: WITHDRAWN ·Phase: PHASE1

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

NCT03790852 ·Status: TERMINATED ·Phase: PHASE1